(TLRY) Tilray - Ratings and Ratios

Exchange: NASDAQ • Country: Canada • Currency: USD • Type: Common Stock • ISIN: US88688T1007

Cannabis, Beverage, Wellness, Hemp, Alcohol

TLRY EPS (Earnings per Share)

EPS (Earnings per Share) of TLRY over the last years for every Quarter: "2020-02": -1.05, "2020-05": -0.65, "2020-08": -0.02, "2020-11": -0.45, "2021-02": -0.06, "2021-05": 0.27, "2021-08": -0.08, "2021-11": 0.03, "2022-02": 0.09, "2022-05": -0.9, "2022-08": -0.13, "2022-11": -0.11, "2023-02": -1.9, "2023-05": -0.15, "2023-08": -0.1, "2023-11": -0.07, "2024-02": -0.12, "2024-05": -0.04, "2024-08": -0.04, "2024-11": -0.0026, "2025-02": -0.8691,

TLRY Revenue

Revenue of TLRY over the last years for every Quarter: 2020-02: 107.392699, 2020-05: 109.729862, 2020-08: 110.599053, 2020-11: 120.573208, 2021-02: 120.573208, 2021-05: 142.236, 2021-08: 168.023, 2021-11: 155.153, 2022-02: 151.871, 2022-05: 153.325, 2022-08: 153.211, 2022-11: 144.136, 2023-02: 145.589, 2023-05: 184.188, 2023-08: 176.949, 2023-11: 193.771, 2024-02: 188.34, 2024-05: 229.882, 2024-08: 200.044, 2024-11: 210.95, 2025-02: 185.78,

Description: TLRY Tilray

Tilray Brands, Inc. is a lifestyle consumer products company with a diverse portfolio of cannabis, beverage alcohol, and wellness products. The company operates globally, with a presence in multiple regions, including Canada, the United States, Europe, Australia, and Latin America. Its product offerings cater to various markets, including medical and adult-use cannabis, pharmaceuticals, and beverage alcohol.

From a business perspective, Tilray has a multi-segment structure, comprising Beverage Alcohol, Cannabis, Distribution, and Wellness. This diversification allows the company to leverage its distribution network and brand portfolio across different product categories. The companys brands, such as Tilray, Aphria, Charlottes Web, and SweetWater Brewing, among others, are marketed and sold through various channels, including retailers, wholesalers, and direct-to-consumer sales.

To evaluate Tilrays performance, key performance indicators (KPIs) such as revenue growth, gross margin, and EBITDA margin can be considered. Given the companys diversified product portfolio and global presence, its essential to analyze its revenue breakdown by segment and region. Additionally, metrics like customer acquisition cost, customer retention rate, and brand recognition can provide insights into the companys marketing and sales effectiveness.

From a financial perspective, Tilrays market capitalization is approximately $499 million USD, with a forward P/E ratio of 1000, indicating a high growth expectation. The companys return on equity (RoE) is -28.82%, suggesting that it is currently unprofitable. To improve its financial performance, Tilray may need to focus on cost optimization, improving operational efficiency, and driving revenue growth through strategic investments in its brands and distribution network.

To further analyze Tilrays prospects, its crucial to examine industry trends, competitive landscape, and regulatory developments in the cannabis and beverage alcohol markets. The companys ability to adapt to changing regulations, consumer preferences, and competitive dynamics will be critical to its long-term success. Key metrics to monitor include the companys cash flow, debt levels, and investments in research and development, marketing, and capital expenditures.

Additional Sources for TLRY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

TLRY Stock Overview

Market Cap in USD 499m
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
GiC Sub-Industry Pharmaceuticals
IPO / Inception 2018-07-19

TLRY Stock Ratings

Growth Rating -92.9
Fundamental -42.7
Dividend Rating 0.0
Rel. Strength -63.3
Analysts 3.67 of 5
Fair Price Momentum 0.27 USD
Fair Price DCF -

TLRY Dividends

Currently no dividends paid

TLRY Growth Ratios

Growth Correlation 3m -37.4%
Growth Correlation 12m -97.4%
Growth Correlation 5y -93.5%
CAGR 5y -38.88%
CAGR/Max DD 5y -0.39
Sharpe Ratio 12m -2.14
Alpha -74.28
Beta 0.564
Volatility 148.38%
Current Volume 51221.2k
Average Volume 20d 30378.4k
Stop Loss 0.6 (-6.3%)
What is the price of TLRY shares?
As of July 12, 2025, the stock is trading at USD 0.64 with a total of 51,221,200 shares traded.
Over the past week, the price has changed by +18.27%, over one month by +51.80%, over three months by +26.06% and over the past year by -65.19%.
Is Tilray a good stock to buy?
Probably not. Based on ValueRay´s Fundamental Analyses, Tilray (NASDAQ:TLRY) is currently (July 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -42.74 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TLRY is around 0.27 USD . This means that TLRY is currently overvalued and has a potential downside of -57.81%.
Is TLRY a buy, sell or hold?
Tilray has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold TLRY.
  • Strong Buy: 4
  • Buy: 0
  • Hold: 8
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for TLRY share price target?
According to our own proprietary Forecast Model, TLRY Tilray will be worth about 0.3 in July 2026. The stock is currently trading at 0.64. This means that the stock has a potential downside of -53.13%.
Issuer Target Up/Down from current
Wallstreet Target Price 1.3 106.3%
Analysts Target Price 1.4 110.9%
ValueRay Target Price 0.3 -53.1%